|
1
|
Cotrina EY, Pinto M, Bosch L, Vilà M, Blasi D, Quintana J, Centeno NB, Arsequell G, Planas A, Valencia G. Modulation of the Fibrillogenesis Inhibition Properties of Two Transthyretin Ligands by Halogenation. J Med Chem 2013; 56:9110-21. [DOI: 10.1021/jm401061w] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Affiliation(s)
- Ellen Y. Cotrina
- Laboratory of Biochemistry, Bioengineering
Department, Institut Químic de Sarrià, Universitat Ramon Llull, ‡Pharmacoinformatics Group, Research
Programme on Biomedical Informatics (GRIB), Department of Experimental
and Health Sciences, Universitat Pompeu Fabra, IMIM (Hospital del Mar Medical Research Institute)-Universitat Pompeu Fabra, §Institut de Química Avançada de Catalunya
(IQAC−CSIC), ⊥Drug Discovery Platform, Parc Científic de Barcelona, Barcelona, Spain
| | - Marta Pinto
- Laboratory of Biochemistry, Bioengineering
Department, Institut Químic de Sarrià, Universitat Ramon Llull, ‡Pharmacoinformatics Group, Research
Programme on Biomedical Informatics (GRIB), Department of Experimental
and Health Sciences, Universitat Pompeu Fabra, IMIM (Hospital del Mar Medical Research Institute)-Universitat Pompeu Fabra, §Institut de Química Avançada de Catalunya
(IQAC−CSIC), ⊥Drug Discovery Platform, Parc Científic de Barcelona, Barcelona, Spain
| | - Lluís Bosch
- Laboratory of Biochemistry, Bioengineering
Department, Institut Químic de Sarrià, Universitat Ramon Llull, ‡Pharmacoinformatics Group, Research
Programme on Biomedical Informatics (GRIB), Department of Experimental
and Health Sciences, Universitat Pompeu Fabra, IMIM (Hospital del Mar Medical Research Institute)-Universitat Pompeu Fabra, §Institut de Química Avançada de Catalunya
(IQAC−CSIC), ⊥Drug Discovery Platform, Parc Científic de Barcelona, Barcelona, Spain
| | - Marta Vilà
- Laboratory of Biochemistry, Bioengineering
Department, Institut Químic de Sarrià, Universitat Ramon Llull, ‡Pharmacoinformatics Group, Research
Programme on Biomedical Informatics (GRIB), Department of Experimental
and Health Sciences, Universitat Pompeu Fabra, IMIM (Hospital del Mar Medical Research Institute)-Universitat Pompeu Fabra, §Institut de Química Avançada de Catalunya
(IQAC−CSIC), ⊥Drug Discovery Platform, Parc Científic de Barcelona, Barcelona, Spain
| | - Daniel Blasi
- Laboratory of Biochemistry, Bioengineering
Department, Institut Químic de Sarrià, Universitat Ramon Llull, ‡Pharmacoinformatics Group, Research
Programme on Biomedical Informatics (GRIB), Department of Experimental
and Health Sciences, Universitat Pompeu Fabra, IMIM (Hospital del Mar Medical Research Institute)-Universitat Pompeu Fabra, §Institut de Química Avançada de Catalunya
(IQAC−CSIC), ⊥Drug Discovery Platform, Parc Científic de Barcelona, Barcelona, Spain
| | - Jordi Quintana
- Laboratory of Biochemistry, Bioengineering
Department, Institut Químic de Sarrià, Universitat Ramon Llull, ‡Pharmacoinformatics Group, Research
Programme on Biomedical Informatics (GRIB), Department of Experimental
and Health Sciences, Universitat Pompeu Fabra, IMIM (Hospital del Mar Medical Research Institute)-Universitat Pompeu Fabra, §Institut de Química Avançada de Catalunya
(IQAC−CSIC), ⊥Drug Discovery Platform, Parc Científic de Barcelona, Barcelona, Spain
| | - Nuria B. Centeno
- Laboratory of Biochemistry, Bioengineering
Department, Institut Químic de Sarrià, Universitat Ramon Llull, ‡Pharmacoinformatics Group, Research
Programme on Biomedical Informatics (GRIB), Department of Experimental
and Health Sciences, Universitat Pompeu Fabra, IMIM (Hospital del Mar Medical Research Institute)-Universitat Pompeu Fabra, §Institut de Química Avançada de Catalunya
(IQAC−CSIC), ⊥Drug Discovery Platform, Parc Científic de Barcelona, Barcelona, Spain
| | - Gemma Arsequell
- Laboratory of Biochemistry, Bioengineering
Department, Institut Químic de Sarrià, Universitat Ramon Llull, ‡Pharmacoinformatics Group, Research
Programme on Biomedical Informatics (GRIB), Department of Experimental
and Health Sciences, Universitat Pompeu Fabra, IMIM (Hospital del Mar Medical Research Institute)-Universitat Pompeu Fabra, §Institut de Química Avançada de Catalunya
(IQAC−CSIC), ⊥Drug Discovery Platform, Parc Científic de Barcelona, Barcelona, Spain
| | - Antoni Planas
- Laboratory of Biochemistry, Bioengineering
Department, Institut Químic de Sarrià, Universitat Ramon Llull, ‡Pharmacoinformatics Group, Research
Programme on Biomedical Informatics (GRIB), Department of Experimental
and Health Sciences, Universitat Pompeu Fabra, IMIM (Hospital del Mar Medical Research Institute)-Universitat Pompeu Fabra, §Institut de Química Avançada de Catalunya
(IQAC−CSIC), ⊥Drug Discovery Platform, Parc Científic de Barcelona, Barcelona, Spain
| | - Gregorio Valencia
- Laboratory of Biochemistry, Bioengineering
Department, Institut Químic de Sarrià, Universitat Ramon Llull, ‡Pharmacoinformatics Group, Research
Programme on Biomedical Informatics (GRIB), Department of Experimental
and Health Sciences, Universitat Pompeu Fabra, IMIM (Hospital del Mar Medical Research Institute)-Universitat Pompeu Fabra, §Institut de Química Avançada de Catalunya
(IQAC−CSIC), ⊥Drug Discovery Platform, Parc Científic de Barcelona, Barcelona, Spain
| |
Collapse
|